Russell Investments Group, Ltd. Astrazeneca PLC Transaction History
Russell Investments Group, Ltd.
- $66.8 Billion
- Q3 2024
A detailed history of Russell Investments Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 856,820 shares of AZN stock, worth $55.7 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
856,820
Previous 856,571
0.03%
Holding current value
$55.7 Million
Previous $66.8 Million
0.06%
% of portfolio
0.1%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
475MCall Options Held
5.14MPut Options Held
3.06M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.09 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.73 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.42 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.39 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.25 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $202B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...